Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5088208 | 1.00 | DNM1 (0.34) | DNM1 | |
| SCHEMBL3982956 | 1.00 | DNM1 (0.34) | DNM1 | |
| SCHEMBL7638293 | 0.88 | — | — | |
| SCHEMBL3988431 | 0.84 | — | — | |
| SCHEMBL7561743 | 0.83 | DNM1 (0.38) | DNM1 | |
| SCHEMBL6065603 | 0.83 | DNM1 (0.38) | DNM1 | |
| SCHEMBL2695539 | 0.83 | DNM1 (0.38) | DNM1 | |
| SCHEMBL5653553 | 0.83 | — | — | |
| Octane SCHEMBL29076189 | 0.82 | TSHR (0.42) | DNM1 | |
| SCHEMBL2694955 | 0.81 | DNM1 (0.41) | DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7098356-B2 | Substituted indenyl metal complexes and polymerization process | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-08-29 | — | — | US | claimed |
| US-20050143536-A1 | Substituted indenyl metal complexes and polymerization process | DOW GLOBAL TECHNOLOGIES LLC | 2005-06-30 | — | — | US | claimed |
| EP-1497301-A1 | SUBSTITUTED POLYCYCLIC, FUSED RING METAL COMPLEXES AND POLYMERIZATION PROCESS | Dow Global Technologies Inc. (US) | 2005-01-19 | — | — | EP | claimed |
| US-20050010039-A1 | Polycyclic fused heteroring compounds metal complexes and polymerization process | GRAF DAVID D (US) | 2005-01-13 | — | — | US | claimed |
| EP-1487886-A1 | SUBSTITUTED INDENYL METAL COMPLEXES AND POLYMERIZATION PROCESS | Dow Global Technologies Inc. (US) | 2004-12-22 | — | — | EP | claimed |
| US-6806327-B2 | POLYMERIZATION CATALYSTS SUCH AS (8-METHYLENE-1,8-DIHYDRODIBENZO(E,H)AZULEN-1-YL)-N-(1,1-DIMETHYLETHYL) DIMETHYLSILANAMIDE TITANIUM (II) 1,4-DIPHENYL-1,2-BUTADIENE | DOW GLOBAL TECHNOLOGIES INC. | 2004-10-19 | — | — | US | claimed |
| WO-2003089444-A1 | SUBSTITUTED POLYCLIC, FUSED RING METAL COMPLEXES AND POLYMERIZATION PROCESS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2003-10-30 | — | — | WO | claimed |
| WO-2003078483-A1 | SUBSTITUTED INDENYL METAL COMPLEXES AND POLYMERIZATION PROCESS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2003-09-25 | — | — | WO | claimed |
| US-20020151662-A1 | Substituted polycyclic, fused ring compounds, metal complexes and polymerization process | DOW GLOBAL TECHNOLOGIES LLC | 2002-10-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143536-A1 | Substituted indenyl metal complexes and polymerization process | ORC3, SOD1, YAP1 | DNM1 2055/4885 |
| US-20050010039-A1 | Polycyclic fused heteroring compounds metal complexes and polymerization process | PICALM, AP1M1, PCBP1 | DNM1 281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.